Table 2.
Distribution of reported cases with a malaria episode and management of childhood malaria by caregivers in the preceding two weeks prior to the study period in Gilgel-Gibe dam area, southwestern Ethiopia, 2007
| Variable | 'At-risk' | 'Control' | OR (95%CI) | p-value |
|---|---|---|---|---|
| Children with a malaria episode in the past two weeks | ||||
| ('at-risk', n = 1003; 'control', n = 953) | 21.8% | 15.8% | 1.49 (0.46-4.76) | 0.483 |
| Children receiving treatment | ||||
| ('at-risk', n = 159; 'control', n = 208) | 75.5% | 84.6% | 0.56 (0.29-1.08) | 0.079 |
| The first action taken | ||||
| ('at-risk', n = 120; 'control', n = 176) | ||||
| Took the child to health services | 60.0% | 68.8% | 0.265 | |
| Treat with anti-malarials at home | 35.8% | 23.3% | ||
| Treat with herbs at home | 2.5% | 6.8% | ||
| Other | 1.7% | 1.1% | ||
| Use of anti-malarial remedies | ||||
| ('at-risk', n = 120; 'control', n = 179) | 81.7% | 79.3% | 1.16 (0.29-4.65) | 0.820 |
| Type of anti-malarial(s) given | ||||
| ('at-risk', n = 98; 'control', n = 142) | ||||
| Coartem® (artemether-lumefantrine (AL)) | 56.1% | 74.6% | 0.392 | |
| Chloroquine (CQ) | 34.7% | 21.8% | ||
| Fansidar® (sulfadoxine-pyrimethamine (SP)) | 9.2% | 2.1% | ||
| Quinine (QN) | 0.0% | 1.4% | ||
| The child finished the dose | ||||
| ('at-risk', n = 142; 'control', n = 98)) | ||||
| Yes | 95.9% | 95.1% | 1.22 (0.13-11.73) | 0.853 |
| Reasons for absence of treatment | ||||
| ('at-risk', n = 39; 'control', n = 32) | ||||
| Lack of money | 76.9% | 53.1% | 0.114 | |
| Health facility very far | 5.2% | 28.1% | ||
| Child not seriously ill | 15.4% | 18.8% | ||
| Others | 2.6% | 0.0% |